These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7656643)

  • 1. Potential therapeutic initiatives for fibrogenic lung diseases.
    Goldstein RH; Fine A
    Chest; 1995 Sep; 108(3):848-55. PubMed ID: 7656643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Perspectives for treatment of pulmonary fibrosis].
    Siemińska A
    Pneumonol Alergol Pol; 1999; 67(11-12):576-82. PubMed ID: 11057110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of pulmonary fibrosis and current treatment.
    Kuwano K; Hagimoto N; Hara N
    Curr Mol Med; 2001 Nov; 1(5):551-73. PubMed ID: 11899231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of granulocyte-macrophage colony-stimulating factor induces pulmonary granulation tissue formation and fibrosis by induction of transforming growth factor-beta 1 and myofibroblast accumulation.
    Xing Z; Tremblay GM; Sime PJ; Gauldie J
    Am J Pathol; 1997 Jan; 150(1):59-66. PubMed ID: 9006322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of apoptosis in pulmonary fibrosis.
    Kuwano K; Hagimoto N; Nakanishi Y
    Histol Histopathol; 2004 Jul; 19(3):867-81. PubMed ID: 15168350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary fibrosis. The fibrogenic factors and therapeutic possibilities].
    Lozano J; Hermosa MJ; Sánchez Martín MM; Angel-Moreno A; de Lera JM; de la Vega M; Sánchez Ramos M; Pérez Arellano JL
    An Med Interna; 2000 Oct; 17(10):549-54. PubMed ID: 11109653
    [No Abstract]   [Full Text] [Related]  

  • 7. Pulmonary fibrosis: cytokines in the balance.
    Coker RK; Laurent GJ
    Eur Respir J; 1998 Jun; 11(6):1218-21. PubMed ID: 9657557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of eosinophils in pulmonary fibrosis (Review).
    Gharaee-Kermani M; Phan SH
    Int J Mol Med; 1998 Jan; 1(1):43-53. PubMed ID: 9852197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of and possible treatment strategies for idiopathic pulmonary fibrosis.
    Gharaee-Kermani M; Phan SH
    Curr Pharm Des; 2005; 11(30):3943-71. PubMed ID: 16305523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy.
    Kinnula VL; Fattman CL; Tan RJ; Oury TD
    Am J Respir Crit Care Med; 2005 Aug; 172(4):417-22. PubMed ID: 15894605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles for insulin-like growth factor I and transforming growth factor-beta in fibrotic lung disease.
    Krein PM; Winston BW
    Chest; 2002 Dec; 122(6 Suppl):289S-293S. PubMed ID: 12475802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective Effect of Infliximab, a Tumor Necrosis Factor-Alfa Inhibitor, on Bleomycin-Induced Lung Fibrosis in Rats.
    Altintas N; Erboga M; Aktas C; Bilir B; Aydin M; Sengul A; Ates Z; Topcu B; Gurel A
    Inflammation; 2016 Feb; 39(1):65-78. PubMed ID: 26253295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta).
    Levi-Schaffer F; Garbuzenko E; Rubin A; Reich R; Pickholz D; Gillery P; Emonard H; Nagler A; Maquart FA
    Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9660-5. PubMed ID: 10449750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment.
    Sime PJ; O'Reilly KM
    Clin Immunol; 2001 Jun; 99(3):308-19. PubMed ID: 11358425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral pirfenidone protects against fibrosis by inhibiting fibroblast proliferation and TGF-β signaling in a murine colitis model.
    Li G; Ren J; Hu Q; Deng Y; Chen G; Guo K; Li R; Li Y; Wu L; Wang G; Gu G; Li J
    Biochem Pharmacol; 2016 Oct; 117():57-67. PubMed ID: 27498142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of lung fibrosis and potential new therapeutic strategies.
    McAnulty RJ; Laurent GJ
    Exp Nephrol; 1995; 3(2):96-107. PubMed ID: 7773645
    [No Abstract]   [Full Text] [Related]  

  • 17. Human amnion epithelial cells prevent bleomycin-induced lung injury and preserve lung function.
    Murphy S; Lim R; Dickinson H; Acharya R; Rosli S; Jenkin G; Wallace E
    Cell Transplant; 2011; 20(6):909-23. PubMed ID: 21092408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokines and pulmonary fibrosis.
    Gauldie J; Jordana M; Cox G
    Thorax; 1993 Sep; 48(9):931-5. PubMed ID: 8236078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of human amniotic epithelial cells in mouse models of bleomycin-induced lung fibrosis: A systematic review and meta-analysis.
    He F; Zhou A; Feng S
    PLoS One; 2018; 13(5):e0197658. PubMed ID: 29772024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis.
    Kolb M; Margetts PJ; Anthony DC; Pitossi F; Gauldie J
    J Clin Invest; 2001 Jun; 107(12):1529-36. PubMed ID: 11413160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.